Yifan Pharmaceutical Co., Ltd. (SHE:002019)

Market Cap	10.75B -21.6%
Revenue (ttm)	5.06B -1.9%
Net Income	355.69M -9.5%
EPS	0.29 -10.4%
Shares Out	1.04B
PE Ratio	35.52
Forward PE	n/a
Dividend	0.10 (0.99%)
Ex-Dividend Date	May 29, 2026

Volume	16,639,105
Open	10.36
Previous Close	10.10
Day's Range	10.28 - 10.68
52-Week Range	10.07 - 16.66
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 24, 2026

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products, vitamins, and polymer materials in China, South Korea, the Philippines, Vietnam, Italy, Thailand, and internationally. It offers pharmaceutical products, such as biopharmaceuticals, chemical drugs, and traditional Chinese medicines; vitamin products, including vitamin B5 and provitamin B5; and active pharmaceutical ingredients. The company was formerly known as Yifan Xinfu Pharmaceutical Co., Ltd. and changed its name to Yifan P...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2000
• Employees: 4,182
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002019

Financial Performance

In 2025, Yifan Pharmaceutical's revenue was 5.13 billion, a decrease of -0.52% compared to the previous year's 5.16 billion. Earnings were 402.02 million, an increase of 4.16%.